OCC Rejects Wise's Trust Bank Bid Over AML Gaps
OCC's first trust-charter denial of the Trump era lands on Wise, just months after a $4.2M multi-state AML settlement, with Wise planning to refile.
OCC's first trust-charter denial of the Trump era lands on Wise, just months after a $4.2M multi-state AML settlement, with Wise planning to refile.
Your own DNA might decide whether CAR-T therapy makes you sick, and a new gene study on Yescarta patients just proved it, six for six.
Sanofi kills its $1.4B Kymab drug in atopic dermatitis, the second autoimmune trial scrapped this summer as Dupixent's patent cliff looms.
Colorado's new chatbot safety law takes effect in 2027, and the rulebook that decides what it covers isn't written yet.
Sanofi wasn't content to just collect royalties, it bought more Scribe stock right as the CRISPR biotech priced its IPO at the top of the range.
New Jersey just became the third state this year to outlaw surveillance pricing, and shelf labels using digital tags are frozen too.
Stripe's in talks to pay $10 billion for OpenRouter, a startup worth $1.3 billion in May, while its $53 billion PayPal bid gets called too low.
M&F's century-old Durham bank sells for up to $53.30 a share as Optus buys its way to becoming the nation's largest Black-owned lender.
An FDA advisory panel voted 8-6 to unrestrict two peptides that RFK Jr. himself uses, over the agency's own scientists' safety objections.
Alaska's Northrim is paying roughly 1.7x book for an 11-branch Oregon lender, its first deal outside the state, in an all-stock swap.
Brussels hit Google with its first-ever DMA fine and a 60-day compliance clock, right as Washington threatens to make it a trade war.
A 270-155 House vote loosens merger review and capital rules for small banks, and 28 advocacy groups say it primes the next bailout.
Travis Kalanick's Atoms closed a $1.7 billion round led by Andreessen Horowitz, with Ben Horowitz taking a board seat to back the industrial AI bet.
The White House says Moonshot built Kimi K3 off 3.4M stolen Claude exchanges and Nvidia GB300 servers. Your vendor diligence checklist just got longer.
NIH just put $1.2B behind Trump's AI science push. For biotech founders, the real number is the $400M NSF is spending on autonomous labs.